These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14651959)

  • 1. Divergent roles of GSK3 and CDK5 in APP processing.
    Ryder J; Su Y; Liu F; Li B; Zhou Y; Ni B
    Biochem Biophys Res Commun; 2003 Dec; 312(4):922-9. PubMed ID: 14651959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing.
    Su Y; Ryder J; Li B; Wu X; Fox N; Solenberg P; Brune K; Paul S; Zhou Y; Liu F; Ni B
    Biochemistry; 2004 Jun; 43(22):6899-908. PubMed ID: 15170327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal glycogen synthase kinase 3β is critical for the antidepressant effect of cyclin-dependent kinase 5 inhibitor in rats.
    Li G; Liu T; Kong X; Wang L; Jin X
    J Mol Neurosci; 2014 Sep; 54(1):92-9. PubMed ID: 24563226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.
    Plattner F; Angelo M; Giese KP
    J Biol Chem; 2006 Sep; 281(35):25457-65. PubMed ID: 16803897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
    Planel E; Yasutake K; Fujita SC; Ishiguro K
    J Biol Chem; 2001 Sep; 276(36):34298-306. PubMed ID: 11441005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice.
    Tomidokoro Y; Ishiguro K; Harigaya Y; Matsubara E; Ikeda M; Park JM; Yasutake K; Kawarabayashi T; Okamoto K; Shoji M
    Neurosci Lett; 2001 Feb; 299(3):169-72. PubMed ID: 11165762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.
    Bhat R; Xue Y; Berg S; Hellberg S; Ormö M; Nilsson Y; Radesäter AC; Jerning E; Markgren PO; Borgegård T; Nylöf M; Giménez-Cassina A; Hernández F; Lucas JJ; Díaz-Nido J; Avila J
    J Biol Chem; 2003 Nov; 278(46):45937-45. PubMed ID: 12928438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of cyclin dependent kinase 5 expression and phosphorylation in amyloid precursor protein (APP)-transfected PC12 cells.
    Czapski GA; Gąssowska M; Songin M; Radecka UD; Strosznajder JB
    FEBS Lett; 2011 Apr; 585(8):1243-8. PubMed ID: 21457712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
    Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY
    Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5.
    Iijima K; Ando K; Takeda S; Satoh Y; Seki T; Itohara S; Greengard P; Kirino Y; Nairn AC; Suzuki T
    J Neurochem; 2000 Sep; 75(3):1085-91. PubMed ID: 10936190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSK3: A potential target and pending issues for treatment of Alzheimer's disease.
    Zhao J; Wei M; Guo M; Wang M; Niu H; Xu T; Zhou Y
    CNS Neurosci Ther; 2024 Jul; 30(7):e14818. PubMed ID: 38946682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roscovitine, a CDK5 Inhibitor, Alleviates Sevoflurane-Induced Cognitive Dysfunction via Regulation Tau/GSK3β and ERK/PPARγ/CREB Signaling.
    Liu J; Yang J; Xu Y; Guo G; Cai L; Wu H; Zhao Y; Zhang X
    Cell Physiol Biochem; 2017; 44(2):423-435. PubMed ID: 29141245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity.
    Wilkaniec A; Gąssowska-Dobrowolska M; Strawski M; Adamczyk A; Czapski GA
    J Neuroinflammation; 2018 Jan; 15(1):1. PubMed ID: 29301548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cdk5 in the pathogenesis of Alzheimer's disease.
    Lau LF; Ahlijanian MK
    Neurosignals; 2003; 12(4-5):209-14. PubMed ID: 14673207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.
    Maldonado H; Ramírez E; Utreras E; Pando ME; Kettlun AM; Chiong M; Kulkarni AB; Collados L; Puente J; Cartier L; Valenzuela MA
    J Neurosci Res; 2011 Sep; 89(9):1489-98. PubMed ID: 21671254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.